NASDAQ:CUE

Cue Biopharma Stock Forecast

etoro logo Buy CUE
*Your capital is at risk
$26.84
-3.56 (-11.71%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of CUE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CUE to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Cue Biopharma Inc. stock price on Friday moving 18.17% between high and low
(Updated on Jul 31, 2026)

Sell candidate since Jul 31, 2026

The Cue Biopharma Inc. stock price fell by -11.71% on the last day (Friday, 31st Jul 2026) from $30.40 to $26.84. During the last trading day the stock fluctuated 18.17% from a day low at $25.26 to a day high of $29.85. The price has fallen in 6 of the last 10 days and is down by -13.86% for this period. Volume has increased on the last day by 207 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 475 thousand shares were bought and sold for approximately $12.75 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.06% during the next 3 months and, with a 90% probability hold a price between $27.86 and $44.19 at the end of this 3-month period.

CUE Signals & Forecast

There are few to no technical positive signals at the moment. The Cue Biopharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $30.47 and $29.88. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 22, 2026, and so far it has fallen -21.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Cue Biopharma Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $25.33 and $24.07. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cue Biopharma Inc. finds support just below today's level at $25.33. If this is broken, then the next support from accumulated volume will be at $24.07 and $23.01.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $4.59 between high and low, or 18.17%. For the last week, the stock has had daily average volatility of 12.89%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CUE) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Cue Biopharma Inc. to open at $27.32, and during the day (based on 14 day Average True Range), to move between $24.89 and $28.79, which gives a possible trading interval of +/-$3.90 (+/-15.66%) up or down from last closing price. If Cue Biopharma Inc. takes out the full calculated possible swing range there will be an estimated 15.66% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $25.33 (5.63%) than the resistance at $29.85 (11.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cue Biopharma Inc. stock A Buy?

The Cue Biopharma Inc. stock holds several negative signals and despite the positive trend, we believe Cue Biopharma Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -3.102 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $27.32 ( 1.78%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CUE Performance

Trading levels for CUE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 31.91 18.88%
R2 30.15 12.34%
R1 29.07 8.31%
Price 26.84
S1 25.56 -4.76%
S2 24.48 -8.79%
S3 22.73 -15.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 31.56 17.59%
R2 30.40 13.26%
R1 29.85 11.21%
Price 26.84
S1 25.33 -5.63%
S2 24.07 -10.34%
S3 23.01 -14.27%

FAQ

What is the symbol for Cue Biopharma Inc. Stock and on which exchange is it traded?
The symbol for Cue Biopharma Inc. is CUE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cue Biopharma Inc. Stock?
The Cue Biopharma Inc. stock holds several negative signals and despite the positive trend, we believe Cue Biopharma Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Cue Biopharma Inc. Stock?
Cue Biopharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cue Biopharma Inc. Stock.

What's the current price of Cue Biopharma Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Cue Biopharma Inc. (CUE) share was $26.84.

What is the 52-week high and low for Cue Biopharma Inc. Stock?
The 52-week high for Cue Biopharma Inc. Stock is $45.50 and the 52-week low is $4.97.

What is the market capitalization of Cue Biopharma Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Cue Biopharma Inc. is 70.534M.

When is the next earnings date for Cue Biopharma Inc.?
The upcoming earnings date for Cue Biopharma Inc. is Aug 18, 2026.
Click to get the best stock tips daily for free!
ABOUT CUE BIOPHARMA INC.
Cue Biopharma
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-10...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE